Molecular Diagnostics

FluoroType® STI

Powered by LiquidArray® | Next generation multiplexing
Next generation multiplexing

LiquidArray® powered syndromic panel for sexually transmitted infections

Next generation multiplexing
Detect 7 STI-causing pathogens from urine and genital swabs in a single well
Powered by LiquidArray®
Pioneering PCR-based technology enables next generation multiplexing for comprehensive pathogen coverage
Confident Neisseria gonorrhoeae reporting
Dual gene detection and integrated analysis provides confidence when reporting NG positive results
Results at a glance
Automated interpretation by FluoroSoftware® XT-IVD provides user-friendly, easy-to-interpret reporting

Syndromic LiquidArray® for STI detection in a single well

FluoroType® STI is a syndromic panel, powered by the pioneering LiquidArray® technology, which covers seven pathogens using nine targets in a single well. Providing next generation multiplexing, it enables the detection and differentiation of the most prevalent bacterial and parasitic pathogens causing major sexually transmitted infections (STIs).

Detection in a single well:

  • Chlamydia trachomatis (dual target)
  • Neisseria gonorrhoeae (dual target)
  • Trichomonas vaginalis
  • Mycoplasma genitalium
  • Mycoplasma hominis
  • Ureaplasma parvum
  • Ureaplasma urealyticum

Dual target detection for challenging diagnoses

The most common bacterial STIs are caused by Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG).

FluoroType® STI offers dual target detection for confidence in reporting the hard-to-detect pathogen NG as well as for CT.

The accurate diagnosis of NG requires the detection of two independent genes to return a positive result – whereas the detection of a single gene may confirm the presence of other Neisseria species. This would support antimicrobial stewardship by prompting further analysis for definitive confirmation of a positive diagnosis before recommending a course of treatment.  The detection of nine targets in a single well supports confident STI reporting and is powered by LiquidArray®.

Powered by LiquidArray®

LiquidArray® from Bruker is a next generation multiplexing PCR-based technology. It is underpinned by the unique features of the FluoroCycler® XT – Bruker’s high performance thermocycler. With precise temperature control and no optical cross-talk or colour compensation, assays are designed with a high number of targets per optical channel. LiquidArray® assays are automatically interpreted and reported providing advanced multiplex results at a glance in a familiar, easy to use format.​

LiquidArray® brings next generation multiplexing for infectious disease diagnostics to the routine clinical microbiology laboratory.

Streamlined workflow from sample to result

Nucleic acid extraction from urine and genital swabs is achieved with the GenoXtract® system, in combination with dedicated extraction kits, providing high quality for optimal PCR performance.

Using LiquidArray® technology, FluoroType® STI runs on the FluoroCycler® XT. The integrated and user-friendly FluoroSoftware® XT-IVD generates a detailed report, together with a results at a glance overview. The output is an easy-to-read analysis visualization for rapid interpretation of results.

The end-to-end workflow for the routine clinical laboratory is one in a range of complete sample-to-result solutions available from Bruker.


Please contact your local representative for availability in your country.

Not for sale in the USA.

Legal Manufacturer is Hain Lifescience GmbH – A Bruker Company